Posted on April 19th, 2010 by
The increased life expectancy of patients with hemophilia that has resulted from advances in treatment places these patients at risk for cardiovascular disease, a researcher said here.
"Screening for cardiovascular risk factors is often overlooked during their annual hemophilia evaluation because of the assumption that these are being managed by their primary care providers," Ming Y. Lim, MB, BChir, of the Mayo Clinic, said at the annual meeting of the Hemophilia and Thrombosis Research Society.
MedPage Today, by Nancy Walsh, 4/18/2010
You must be logged-in to the site to post a comment.